We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-3.07%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$46.8B
AUM Growth
+$933M
(+2%)
Cap. Flow
+$2.08B
Cap. Flow
% of AUM
4.45%
Top 10 Holdings %
Top 10 Hldgs %
8.13%
Holding
3,617
New
458
Increased
1,225
Reduced
1,321
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.31% |
| 4 | Industrials | 9.8% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORKA
2751
Oruka Therapeutics
ORKA
$5.96B
| $224K | ﹤0.01% |
+21,831
| New | +$272K |
|
2752
Tucows
TCX
$175M
| $223K | ﹤0.01% |
+13,233
| New | +$230K |
|
2753
Consolidated Water Co
CWCO
$488M
| $223K | ﹤0.01% |
+9,117
| New | +$243K |
|
2754
Hyliion Holdings
HYLN
$690M
| $223K | ﹤0.01% |
158,947
+101,347
| +176% | +$201K |
|
2755
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.34B
| $222K | ﹤0.01% |
1,000
-61,600
| -98% | -$15.2M |
|
2756
Protalix BioTherapeutics
PLX
$198M
| $221K | ﹤0.01% |
+86,354
| New | +$206K |
|
|
CNTA
2757
DELISTED
Centessa Pharmaceuticals
CNTA
| $220K | ﹤0.01% |
15,300
-22,600
| -60% | -$370K |
|
2758
Thor Industries
THO
$4.14B
| $220K | ﹤0.01% |
+2,900
| New | +$273K |
|
2759
Boston Beer
SAM
$1.92B
| $219K | ﹤0.01% |
916
-23,113
| -96% | -$5.63M |
|
2760
Lineage Cell Therapeutics
LCTX
$278M
| $217K | ﹤0.01% |
480,423
+178,879
| +59% | +$105K |
|
|
SLN
2761
Silence Therapeutics
SLN
$564M
| $214K | ﹤0.01% |
76,008
-66,044
| -46% | -$322K |
|
|
LENZ
2762
LENZ Therapeutics
LENZ
$168M
| $214K | ﹤0.01% |
8,322
-8,757
| -51% | -$216K |
|
|
NOTE
2763
DELISTED
FiscalNote
NOTE
| $214K | ﹤0.01% |
+22,036
| New | +$331K |
|
2764
Invesco Bloomberg Pricing Power ETF
POWA
$183M
| $214K | ﹤0.01% |
+2,600
| New | +$216K |
|
|
ILPT
2765
Industrial Logistics Properties Trust
ILPT
$586M
| $213K | ﹤0.01% |
62,001
+801
| +1% | +$2.99K |
|
|
FLOC
2766
Flowco Holdings
FLOC
$911M
| $213K | ﹤0.01% |
+8,300
| New | +$219K |
|
|
HIVE
2767
HIVE Digital Technologies
HIVE
$777M
| $211K | ﹤0.01% |
145,485
-561,420
| -79% | -$1.38M |
|
2768
Cognyte Software
CGNT
$680M
| $211K | ﹤0.01% |
+27,044
| New | +$246K |
|
2769
Tenaya Therapeutics
TNYA
$163M
| $210K | ﹤0.01% |
367,629
+322,858
| +721% | +$319K |
|
2770
MVB Financial
MVBF
$389M
| $209K | ﹤0.01% |
12,047
-10,362
| -46% | -$195K |
|
2771
Lyell Immunopharma
LYEL
$360M
| $209K | ﹤0.01% |
19,384
+9,159
| +90% | +$112K |
|
2772
Transcat
TRNS
$871M
| $208K | ﹤0.01% |
2,799
-2,474
| -47% | -$207K |
|
2773
Corteva
CTVA
$51.3B
| $208K | ﹤0.01% |
3,308
-14,400
| -81% | -$890K |
|
|
KRMN
2774
Karman Holdings
KRMN
$7.72B
| $208K | ﹤0.01% |
+6,220
| New | +$201K |
|
2775
Cato Corp
CATO
$66.1M
| $207K | ﹤0.01% |
62,183
-38,864
| -38% | -$131K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Two Sigma Investments held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Two Sigma Investments deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- Two Sigma Investments's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- Two Sigma Investments added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- Two Sigma Investments's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- Two Sigma Investments fully exited Coinbase in Q1 2025, selling an estimated $45M.
- Two Sigma Investments's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- Two Sigma Investments opened 458 new positions and closed 453 in Q1 2025.
- Two Sigma Investments's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.